| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 1,480,060 | 53,563,000 | 85.86% | ||
| 2 | ALIMERA SCIENCES INC | 3,148,355 | 4,691,000 | 7.52% | ||
| 3 | PULMATRIX INC | 1,591,862 | 2,627,000 | 4.21% | ||
| 4 | CERULEAN PHARMA INC | 1,437,441 | 1,505,000 | 2.41% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001907, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
